<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=384506&amp;fmt=gif">
Skip to content
{
Book a Demo

    CDD Blog

      Filter by Topic

      CDD Blog
      6 min   September 19, 2011
      Collaboration as the key to turning around the drug discovery business (Part 5) – a Monte Carlo Simulation
      Read More
      CDD Blog
      2 min   September 15, 2011
      CDD’s Sean Ekins Elected to Pistoia Alliance BOD
      Read More
      CDD Blog
      4 min   September 13, 2011
      National Library of Medicine Awards Phase I SBIR Grant to Collaborative Drug Discovery, Inc. to Develop Computational Tools For Biocomputation across distributed private datasets to enhance drug disco
      Read More
      4 min   September 13, 2011
      National Library of Medicine Awards Phase I SBIR Grant to Collaborative Drug Discovery, Inc.
      Read More
      CDD Blog
      3 min   September 6, 2011
      What’s wrong with the Pistoia Alliance…and why we’re renewing our annual membership! (Part 2)
      Read More
      CDD Blog
      3 min   August 31, 2011
      What’s wrong with the Pistoia Alliance…and why we’re renewing our annual membership! (Part 1)
      Read More
      CDD Blog
      4 min   August 25, 2011
      Collaborative Drug Repositioning Profiled in the Wall Street Journal
      Read More
      CDD Vault Updates
      2 min   August 22, 2011
      CDD Vault Update: Importing Data with a Simpler Mapper (That Does More)
      Read More
      CDD Blog
      7 min   August 18, 2011
      Collaboration as the key to turning around the drug discovery business (Part 4) – Collaboration and Innovation
      Read More
      CDD Blog
      5 min   August 18, 2011
      Congratulations to researchers from Plexxikon and Genentech on the FDA Approval of Zelboraf – an oral, small molecule kinase inhibitor for skin cancer
      Read More
      1 min   August 8, 2011
      CDD FOUNDER DR. BARRY BUNIN ON FOUNDERLY
      Read More
      CDD Blog
      8 min   August 7, 2011
      Collaboration as the key to turning around the drug discovery business (Part 3) - A Solution
      Read More